Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2003
03/20/2003US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055037 Benzimidazole and indole derivatives as CRF receptor modulators
03/20/2003US20030055033 Azetidine derivatives, their preparation and pharmaceutical compositions containing them
03/20/2003CA2460347A1 3-glyoxlylamideindoles for treating cancer
03/20/2003CA2460345A1 2-aroylimidazole compounds for treating cancer
03/20/2003CA2459879A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459360A1 4-alkyl-substitute thienyloxy-pyridines
03/19/2003EP1293507A1 Process for producing crystal
03/19/2003EP1293503A1 Triazole derivatives
03/19/2003EP1293501A1 Substituted 1-aryl-pyrazoles and their use as pesticides
03/19/2003EP1293214A2 LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation
03/19/2003EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292590A1 Admantane derivatives
03/19/2003EP1292586A1 Process for the preparation of pyrazolopyrimidinones
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292575A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292300A1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus
03/19/2003EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
03/19/2003EP0955293B1 Urea derivatives
03/19/2003EP0945439B1 Aminopyrazole derivatives
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003EP0900203B1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403453A Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1103335C Processfor producing 2,5-disubstituted pyridines
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534654 Process for preparing imidazoquinolinamines
03/18/2003US6534651 Substituted isoindolinone derivatives
03/18/2003US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates
03/18/2003US6534574 Bicyclo(2.2.1)heptane dicarboxylate salts; clarifying polyolefins; shelf life, storage stability
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534532 Carbanilides as pesticides
03/18/2003US6534529 Synergistic insecticide mixtures
03/18/2003US6534525 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
03/18/2003US6534524 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
03/18/2003US6534520 Antiviral compounds
03/18/2003US6534519 Phenanthridine-N-oxides with PDE-IV inhibiting activity
03/18/2003US6534510 Anticoagulants
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534508 Treatment of Mycobacteria infection by administering (S)-lomefloxacin or a pharmaceutically acceptable salt thereof free of its (R)-stereoisomer
03/18/2003US6534507 Methods for treating psychological disorders using bioactive metabolites of gepirone
03/18/2003US6534504 Increasing the quantity of meat or improving the quality of meat obtained from a livestock animal, comprising administering to the animal an effective amount of a compound represented by the following structural formula:
03/18/2003US6534502 Antihistamines, antiinflammatory agents
03/18/2003US6534498 Protease inhibitors
03/18/2003US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or
03/18/2003US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
03/18/2003US6534447 Herbicidal pyridine compounds
03/18/2003US6534445 Substituted pyridine herbicides
03/18/2003CA2362944C Optical isomers of ¬3-(1,1-dialkylated)-1-aminomethyl-pyrrolidine|
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/18/2003CA2200607C Processes and intermediates for preparing 5,7-dihydro-3-[2-{1-benzylpiperidin-4-yl}ethyl]-6h-pyrrolo-[4,5-f]-1,2-benzisoxazol-6-one
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003021355A1 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003WO2003020715A1 Aminopyrrole compounds as antiinflammatory agents
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020699A2 Tyrosine kinase inhibitors
03/13/2003WO2003020281A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020276A1 Tyrosine kinase inhibitors
03/13/2003WO2003020217A2 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002096361A3 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
03/13/2003WO2001097848A3 Vitronectin receptor antagonist pharmaceuticals
03/13/2003US20030050330 And inflammation-associated disorders, such as arthritis
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050316 An amine compound of phenyl or hetero ring for treating Alzheimer's disease
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050288 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; oral contraception using multiphase progestotational agents, antiprogestins, indole or thiophene derivatives and placebo
03/13/2003US20030050254 Derivatives of erythromycin, their preparation process and their use as medicaments
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/13/2003CA2458808A1 Aminopyrrole compounds as antiinflammatory agents
1 ... 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 ... 1080